The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...
Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement ... when it came to inflammatory reactions in the eye. Earlier this year, Novartis halted three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback